Related Experiment Video
Updated: Jan 23, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Cardiovascular Outcomes of Romosozumab and Protective Role of Alendronate
Kamyar Asadipooya1, Ada Weinstock2
1From the Division of Endocrinology and Molecular Medicine, Department of Medicine, University of Kentucky, Lexington (K.A.).
Insights
Romosozumab treats osteoporosis by activating the Wnt pathway, which may increase cardiovascular risks. Combining romosozumab with bisphosphonates may reduce these adverse cardiovascular events.
Area of Science:
- Bone biology and cardiovascular health
- Endocrinology and metabolic diseases
Background:
- Osteoporosis and cardiovascular diseases are significant public health concerns.
- Bone and cardiovascular remodeling share common biological pathways.
- Romosozumab, an antisclerostin antibody, improves osteoporosis outcomes but may pose cardiovascular risks due to Wnt pathway activation.
Purpose of the Study:
- To explore the potential cardiovascular risks associated with romosozumab treatment.
- To investigate the combined therapeutic potential of romosozumab and bisphosphonates for managing osteoporosis and mitigating cardiovascular risks.
Main Methods:
- Review of biological markers and pathways involved in bone and cardiovascular remodeling.
- Analysis of the Wnt pathway's role in cardiovascular processes.
- Evaluation of the opposing effects of bisphosphonates and Wnt activation on vascular health.
Main Results:
- Sclerostin inhibition by romosozumab activates the Wnt pathway, potentially impacting cardiovascular remodeling.
- Bisphosphonates and Wnt pathway activation have opposing effects on endothelial dysfunction, lipid accumulation, and vascular calcification.
Conclusions:
- The combination of romosozumab and bisphosphonates presents a novel therapeutic strategy.
- This combination may reduce the risk of adverse cardiovascular events in patients receiving romosozumab for osteoporosis.
Abstract:
Osteoporosis and cardiovascular diseases are major public health issues. Bone and cardiovascular remodeling share multiple biological markers and pathways. Medical intervention, such as using romosozumab, an antisclerostin antibody, improves the clinical outcome of osteoporosis. However, blocking sclerostin leads to Wnt (wingless/integrated) activation and participation in the cardiovascular remodeling process, which could potentially lead to adverse events. Based on the opposing roles of bisphosphonates and the Wnt pathway on endothelial dysfunction, lipid accumulation and calcification of the vessel walls, the combination of romosozumab and bisphosphonates could be a new therapeutic approach to reducing the risks of adverse cardiovascular events in romosozumab receivers. Visual Overview- An online visual overview is available for this article.
Related Concept Videos
Predicting Reaction Outcomes
Overview of the Cardiovascular System
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Zones of Protection
Protective zones are defined by closed dashed lines, containing one or more components. A key characteristic of these zones is the strategic placement of...
Protection of Alcohols
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...

